av/onxeo-sa--big.svg

EURONEXT:ALVIO

Valerio Therapeutics Société anonyme

  • Stock

EUR

Last Close

0.10

26/07 15:35

Market Cap

15.49M

Beta: 1.63

Volume Today

22.25K

Avg: 76.64K

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
1.47M
-
22.08M
1,405.44%
3.48M
84.23%
4.42M
27.05%
9.51M
114.85%
6.13M
35.54%
4.29M
30.01%
1.78M
58.58%
4.06M
128.72%
1.44M
64.48%
1.80M
24.74%
cost of revenue
264.27K
-
248.85K
5.84%
337K
35.42%
655K
94.36%
634K
3.21%
215K
66.09%
350K
62.79%
1.94M
454.86%
368K
81.05%
514K
39.67%
533K
3.70%
gross profit
1.20M
-
21.83M
1,715.61%
3.15M
85.59%
3.77M
19.84%
8.87M
135.37%
5.91M
33.36%
3.94M
33.39%
-166K
104.22%
3.69M
2,325.30%
929K
74.85%
1.27M
36.38%
selling and marketing expenses
6.67M
-
6.54M
1.99%
6.34M
3.10%
5.12M
19.17%
general and administrative expenses
10.71M
-
5.72M
-
2.96M
48.16%
2.42M
18.39%
2.34M
3.31%
2.63M
12.70%
selling general and administrative expenses
10.71M
-
6.67M
37.67%
6.54M
1.99%
6.34M
3.10%
5.12M
19.17%
5.72M
11.58%
2.96M
48.16%
2.42M
18.39%
2.34M
3.31%
2.63M
12.70%
10.23M
288.08%
research and development expenses
9.61M
-
12.68M
31.87%
14.07M
10.97%
15.36M
9.21%
4.93M
67.94%
5.84M
18.55%
2.11M
63.92%
3.05M
44.95%
7.87M
157.79%
10.30M
30.83%
other expenses
-243K
-
10.01M
4,218.52%
-581K
105.81%
389K
166.95%
153K
60.67%
cost and expenses
16.90M
-
22.70M
34.27%
25.66M
13.04%
27.59M
7.54%
75.88M
175.02%
21.77M
71.31%
20.08M
7.74%
11.19M
44.31%
9.63M
13.88%
18.56M
92.65%
20.85M
12.38%
operating expenses
16.64M
-
22.45M
34.91%
25.32M
12.79%
26.94M
6.39%
75.25M
179.36%
21.55M
71.35%
19.73M
8.45%
9.24M
53.16%
9.26M
0.23%
18.04M
94.75%
20.37M
12.92%
interest expense
287.26K
-
3.16M
1,000.93%
1.21M
61.90%
437K
63.73%
1.12M
155.84%
1.04M
7.25%
1.04M
0%
959K
7.52%
1.70M
76.85%
2.19M
29.07%
ebitda
-14.80M
-
3.45M
123.28%
-18.19M
627.89%
-19.80M
8.87%
-25.50M
28.74%
-947K
96.29%
7.37M
878.67%
-8.18M
210.92%
-4.90M
40.14%
-17.08M
248.92%
-18.57M
8.72%
operating income
-15.44M
-
-616.07K
96.01%
-22.18M
3,499.61%
-23.17M
4.47%
-19.19M
17.17%
-15.64M
18.47%
-9.79M
37.39%
-7.81M
20.22%
-5.58M
28.56%
-17.11M
206.61%
-19.05M
11.32%
depreciation and amortization
3.42K
-
842.09K
24,529.83%
2.21M
162.08%
1.61M
27.23%
40.25M
2,406.41%
9.18M
77.21%
25.39M
176.77%
-8.21M
132.35%
511K
106.22%
-167K
132.68%
480K
387.43%
total other income expenses net
116.59K
-
-4.93M
4,330.69%
413K
108.37%
1.06M
157.14%
-47.68M
4,589.45%
4.49M
109.41%
-26.26M
685.51%
9.66M
136.79%
-1.08M
111.20%
-2.16M
99.45%
-1.27M
40.96%
income before tax
-15.32M
-
-5.55M
63.78%
-21.76M
292.21%
-22.11M
1.58%
-66.87M
202.48%
-11.16M
83.31%
-36.05M
223.09%
1.85M
105.12%
-6.66M
460.80%
-19.27M
189.21%
-20.33M
5.47%
income tax expense
633.43K
-
2.15M
239.39%
-2.35M
209.45%
566K
124.05%
-7.80M
1,477.56%
-1.76M
77.43%
-2.32M
32.05%
757K
132.57%
100K
86.79%
285K
185%
17K
94.04%
net income
-15.32M
-
-7.70M
49.75%
-19.41M
152.11%
-22.67M
16.81%
-59.07M
160.56%
-9.40M
84.09%
-33.73M
258.85%
1.09M
103.23%
-5.94M
645.18%
-19.56M
229.49%
-20.34M
4.00%
weighted average shs out
20.82M
-
40.81M
96.03%
40.77M
0.09%
47.32M
16.05%
50.95M
7.66%
53.62M
5.24%
61.38M
14.48%
73.15M
19.19%
88.21M
20.58%
105.75M
19.88%
135.63M
28.26%
weighted average shs out dil
20.82M
-
40.81M
96.03%
40.81M
0%
47.35M
16.03%
51.03M
7.76%
53.62M
5.07%
61.38M
14.48%
75.87M
23.61%
88.21M
16.27%
105.75M
19.88%
135.63M
28.26%
eps
-0.74
-
-0.19
74.32%
-0.48
152.63%
-0.48
0%
-1.16
141.67%
-0.18
84.48%
-0.55
205.56%
0.01
102.71%
-0.07
551.68%
-0.18
167.46%
-0.15
16.67%
epsdiluted
-0.74
-
-0.19
74.32%
-0.48
152.63%
-0.48
0%
-1.16
141.67%
-0.18
84.48%
-0.55
205.56%
0.01
102.62%
-0.07
567.36%
-0.18
167.46%
-0.15
16.67%

All numbers in EUR (except ratios and percentages)